Role of TNF-α and its receptors in pericoronitis

Journal of Dental Research

Volumn 84, Issue 12, 2005, Pages 1178-1182

  Beklen, A ^a,b,c   Laine, M ^a,b   Venta I ^d   Hyrkas T ^d   Konttinen, Y T ^a,e,f,g  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BOGAZICI UNIVERSITY   (Turkey)

^d Finnish Student Health Service   (Finland)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f Hospital for Joint Replacement   (Finland)

^g BIOMEDICUM HELSINKI   (Finland)

Author keywords

Pericoronitis; TNF R1; TNF R2; Tumor necrosis factor alpha

Indexed keywords

GELATINASE B; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CAPILLARY; CYTOLOGY; DRUG ANTAGONISM; EPITHELIUM CELL; FIBROBLAST; GINGIVA; GINGIVA DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VENULE;

ADULT; CAPILLARIES; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MACROPHAGES; MATRIX METALLOPROTEINASE 9; PERICORONITIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VENULES;

EID: 33644807380     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508401216     Document Type: Article

References (30)

1. Aggarwal BB (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745-756.
2. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996). Periodontal disease and cardiovascular disease. J Periodontol 67:1123-1137.
3. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.
4. Blakey GH, White RP Jr, Offenbacher S, Phillips C, Delano EO, Maynor G (1996). Clinical/biological outcomes of treatment for pericoronitis. J Oral Maxillofac Surg 54:1150-1160.
5. Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, et al. (1992). Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum 35:1170-1178.
6. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T (1997). Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis, and Treponema denticola. J Clin Periodontol 24:237-248.
7. Ferrero E, Zocchi MR, Magni E, Panzeri MC, Curnis F, Rugarli C, et al. (2001). Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability. Am J Physiol Cell Physiol 281:C1173-C1179.
8. Gemmell E, Marshall RI, Seymour GJ (1997). Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 14:112-143.
9. Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G, Bertini R (2000). Lps induces IL-6 in the brain and in serum largely through TNF production. Cytokine 12:1205-1210.
10. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, et al. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 272:31504-31509.
11. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P (1996). Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156:2558-2565.
12. Kacinski BM, Flick M (2001). Apoptosis and cutaneous T cell lymphoma. Ann NY Acad Sci 941:194-199.
13. Klinger MM, Rahemtulla F, Prince CW, Lucas LC, Lemons JE (1998). Proteoglycans at the bone-implant interface. Crit Rev Oral Biol Med 9:449-463.
14. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, et al. (1993). Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443-1453.
15. Laine M, Venta I, Hyrkas T, Ma J, Konttinen YT (2003). Chronic inflammation around painless partially erupted third molars. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:277-282.
16. Lawson C, Ainsworth M, Yacoub M, Rose M (1999). Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J Immunol 162:2990-2996.
17. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. (1999). Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354:1932-1939.
18. Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, et al. (2003). Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 85:1196-1201.
19. Oates TW, Graves DT, Cochran DL (2002). Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 29:137-143.
20. Orbak R, Dayi E (2003). Flow-cytometric analysis of T-lymphocyte subsets after different treatment methods in patients with pericoronitis. J Oral Maxillofac Surg 61:201-205.
21. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL (2003). Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2:736-746.
22. Peltroche-Llacsahuanga H, Reichhart E, Schmitt W, Lutticken R, Haase G (2000). Investigation of infectious organisms causing pericoronitis of the mandibular third molar. J Oral Maxillofac Surg 58:611-616.
23. Siegel SA, Shealy DJ, Nakada MT, Le J, Woulfe DS, Probert L, et al. (1995). The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 7:15-25.
24. Springer TA (1995). Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57:827-872.
25. Stemerman MB (2000). Lipoprotein effects on the vessel wall. Circ Res 86:715-716.
26. Szlosarek PW, Balkwill FR (2003). Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 4:565-573.
27. Tervahartiala T, Koski H, Xu JW, Häyrinen-Immonen R, Hietanen J, Sorsa T, et al. (2001) Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 80:1535-1539.
28. VanSaun M, Herrera AA, Werle MJ (2003). Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice. J Neurocytol 32:1129-1142.
29. Vilcek J, Lee TH (1991). Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316.
30. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. (1999). A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259.